This company has been marked as potentially delisted and may not be actively trading. TRACON Pharmaceuticals (TCON) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsDividendEarningsInsider TradesTrendsBuy This Stock TRACON Pharmaceuticals (NASDAQ:TCON) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.27%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$1.82 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$2,188.80 Get TCON Insider Trade Alerts Want to know when executives and insiders are buying or selling TRACON Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TCON Insider Buying and Selling by Quarter TRACON Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/26/2023Charles TheuerCEOBuy199$13.20$2,626.80 3/9/2023Opaleye Management Inc.Major ShareholderBuy8,725$27.60$240,810.00 2/28/2023Charles TheuerCEOBuy10$30.40$304.00 1/18/2023Charles TheuerCEOBuy340$32.40$11,016.00 12/14/2022Charles TheuerCEOBuy1,150$25.80$29,670.00 12/14/2022Opaleye Management Inc.Major ShareholderBuy8,375$25.00$209,375.00 12/6/2022Opaleye Management Inc.Major ShareholderSell76$28.80$2,188.80 11/18/2022Charles TheuerCEOBuy695$28.20$19,599.00 11/2/2022Charles TheuerCEOBuy300$31.80$9,540.00 10/18/2022Opaleye Management Inc.Major ShareholderBuy625$33.00$20,625.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/7/2022Charles TheuerCEOBuy250$35.40$8,850.00 10/3/2022Charles TheuerCEOBuy250$33.40$8,350.00 9/29/2022Opaleye Management Inc.Major ShareholderBuy470$34.80$16,356.00 9/27/2022Opaleye Management Inc.Major ShareholderBuy85$33.80$2,873.00 9/22/2022Charles TheuerCEOBuy250$35.20$8,800.00 9/22/2022Opaleye Management Inc.Major ShareholderBuy865$34.60$29,929.00 9/19/2022Opaleye Management Inc.Major ShareholderBuy250$37.40$9,350.00 9/12/2022Scott B BrownCFOBuy125$40.40$5,050.00 7/26/2022Opaleye Management Inc.Major ShareholderBuy112$34.40$3,852.80 7/22/2022Charles TheuerCEOBuy225$37.00$8,325.00 7/14/2022Opaleye Management Inc.Major ShareholderBuy359$36.20$12,995.80 7/12/2022Charles TheuerCEOBuy150$37.40$5,610.00 6/24/2022Opaleye Management Inc.Major ShareholderBuy570$27.80$15,846.00 6/21/2022Opaleye Management Inc.Major ShareholderBuy42,099$26.20$1,102,993.80 5/10/2022Opaleye Management Inc.Major ShareholderBuy485$35.20$17,072.00 5/9/2022Charles TheuerCEOBuy500$37.00$18,500.00 5/6/2022Charles TheuerCEOBuy125$39.40$4,925.00 (Data available from 1/1/2013 forward) TCON Insider Trading Activity - Frequently Asked Questions Who is on TRACON Pharmaceuticals's Insider Roster? The list of insiders at TRACON Pharmaceuticals includes Charles Theuer, Opaleye Management Inc., and Scott B Brown. Learn more on insiders at TCON. What percentage of TRACON Pharmaceuticals stock is owned by insiders? 5.27% of TRACON Pharmaceuticals stock is owned by insiders. Learn more on TCON's insider holdings. TRACON Pharmaceuticals Key ExecutivesDr. Charles P. Theuer M.D. (Age 60)Ph.D., Chairman, CEO & President Compensation: $646.6kMr. Scott B. Brown CPA (Age 43)M.S., Chief Financial Officer Compensation: $403.1kDr. James L. Freddo M.D. (Age 69)Chief Medical Officer Mr. Ya HuangExecutive Director of Statistical Programming More Insider Trading Tools from MarketBeat Related Companies Virpax Pharmaceuticals Insider Buying TFF Pharmaceuticals Insider Buying TC Biopharm Insider Buying Vincerx Pharma Insider Buying Aditxt Insider Buying Calithera Biosciences Insider Buying Evelo Biosciences Insider Buying Smart for Life Insider Buying Comera Life Sciences Insider Buying Genocea Biosciences Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:TCON) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRACON Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TCON Stock Free TCON Stock Alerts